Skip to content

Role of vitamin-D supplementation in addition to standard treatment of asthma in children

Vitamin -D Supplementation as an Adjunct to Standard Treatment of Asthma in Children: A Randomized Control Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/014777
Enrollment
70
Registered
2018-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Children of Asthma coming to paediatric OPD Health Condition 2: J454- Moderate persistent asthma

Interventions

Intervention1: Vitamin-D: 1.Initial evaluation included a detailed medical history and complete physical and systemic examination. 2.Spirometry with bronchodilator reversibility will be done in all

Sponsors

AIIMS Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children 6 to 18 years of age, newly diagnosed case of asthma by Pediatrician. (Clinical and/or PFT). OR follow-up case of asthma in chest clinic at AIIMS 2. Those willing to take medication for 3 months and regular follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with history of prematurity, bronchopulmonary dysplasia, coexisting primary parenchymal pulmonary disease (e.g. cystic fibrosis) or coexisting congenital/acquired heart diseases, and patients of epilepsy on anticonvulsants. 2. Known case of Vitamin â??D deficiency. 3. History of intake of Vitamin-D and calcium in past 1 month. 4. Known case of any disease involving Vitamin-D & calcium metabolism. 5. Consent not given. 6. Those with hypercalcemia or allergy to Vitamin- D.

Design outcomes

Primary

MeasureTime frame
1. Primary outcome measure will be ACT score (which is a validated score and contained 5 items with minimum score of 5 to maximum score of 25) at 3 monthsTimepoint: 1. Enrollment will be done in 1st 3 months 2. Interventions will start at the time of enrollment. 3. Participants will be asked to visit clinic after every 15 days for follow-up.

Secondary

MeasureTime frame
Secondary outcome measure will be FEV1, fraction excretion of nitric oxide, number of asthma exacerbation, serum 25-OH vitamin D3 at 3 months and adverse outcome, no. of emergency visits, use of systemic steroid.Timepoint: 1. Enrollment will be done in 1st 3 months 2. Interventions will start at the time of enrollment. 3. Participants will be asked to visit clinic after every 15 days for follow-up.

Countries

India

Contacts

Public ContactDr Chirag Thakur

AIIMS, Jodhpur

jpgoyal@rediffmail.com8475000270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026